• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人脑中脑帕金森病模型中,星形胶质细胞促成Toll样受体2介导的神经退行性变和α-突触核蛋白病理改变。

Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson's model.

作者信息

Weiss Fiona, Hughes Laura, Fu Yuhong, Bardy Cedric, Halliday Glenda M, Dzamko Nicolas

机构信息

School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, NSW, 2050, Australia.

Laboratory for Human Neurophysiology and Genetics, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.

出版信息

Transl Neurodegener. 2024 Dec 16;13(1):62. doi: 10.1186/s40035-024-00448-3.

DOI:10.1186/s40035-024-00448-3
PMID:39681872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11648304/
Abstract

BACKGROUND

Parkinson's disease (PD) is characterised by degeneration of ventral midbrain dopaminergic (DA) neurons and abnormal deposition of α-synuclein (α-syn) in neurons. Activation of the innate immune pathogen recognition receptor toll-like receptor 2 (TLR2) is associated with exacerbation of α-syn pathology. TLR2 is increased on neurons in the PD brain, and its activation results in the accumulation and propagation of α-syn through autophagy inhibition in neurons. In addition to the aggregation and propagation of pathological α-syn, dysfunction of astrocytes may contribute to DA neuronal death and subsequent clinical progression of PD. However, the role of astrocytes in TLR2-mediated PD pathology is less explored but important to address, given that TLR2 is a potential therapeutic target for PD.

METHODS

Induced pluripotent stem cells from three controls and three PD patients were differentiated into a midbrain model comprised of neurons (including DA neurons) and astrocytes. Cells were treated with or without the TLR2 agonist Pam3CSK4, and α-syn pathology was seeded using pre-formed fibrils. Confocal imaging was used to assess lysosomal function and α-syn pathology in the different cell types, as well as DA neuron health and astrocyte activation.

RESULTS

TLR2 activation acutely impaired the autophagy lysosomal pathway, and potentiated α-syn pathology seeded by pre-formed fibrils in PD neurons and astrocytes, leading to degeneration and loss of DA neurons. The astrocytes displayed impaired chaperone-mediated autophagy reducing their ability to clear accumulated α-syn, and increases of A1 neurotoxic phenotypic proteins SerpinG1, complement C3, PSMB8 and GBP2. Moreover, the phenotypic changes in astrocytes correlated with a specific loss of DA neurons.

CONCLUSIONS

Taken together, these results support a role for astrocyte dysfunction in α-syn accumulation and DA neuronal loss following TLR2 activation in PD.

摘要

背景

帕金森病(PD)的特征是中脑腹侧多巴胺能(DA)神经元变性以及神经元中α-突触核蛋白(α-syn)异常沉积。先天免疫病原体识别受体Toll样受体2(TLR2)的激活与α-syn病理学的加重有关。TLR2在PD脑内的神经元上表达增加,其激活通过抑制神经元自噬导致α-syn的积累和传播。除了病理性α-syn的聚集和传播外,星形胶质细胞功能障碍可能导致DA神经元死亡及随后的PD临床进展。然而,鉴于TLR2是PD的一个潜在治疗靶点,星形胶质细胞在TLR2介导的PD病理学中的作用尚未得到充分研究,但很重要。

方法

从三名对照者和三名PD患者的诱导多能干细胞分化成由神经元(包括DA神经元)和星形胶质细胞组成的中脑模型。细胞用或不用TLR2激动剂Pam3CSK4处理,并使用预形成的纤维种入α-syn病理学。共聚焦成像用于评估不同细胞类型中的溶酶体功能和α-syn病理学,以及DA神经元健康和星形胶质细胞激活。

结果

TLR2激活急性损害自噬溶酶体途径,并增强由预形成纤维在PD神经元和星形胶质细胞中种入的α-syn病理学,导致DA神经元变性和丢失。星形胶质细胞显示伴侣介导的自噬受损,降低了它们清除积累的α-syn的能力,并增加了A1神经毒性表型蛋白丝氨酸蛋白酶抑制剂G1、补体C3、蛋白酶体β亚基8和鸟苷结合蛋白2。此外,星形胶质细胞的表型变化与DA神经元的特异性丢失相关。

结论

综上所述,这些结果支持星形胶质细胞功能障碍在PD中TLR2激活后α-syn积累和DA神经元丢失中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/42e5675422d4/40035_2024_448_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/6b03b6499dba/40035_2024_448_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/90dcdde67bbd/40035_2024_448_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/387ff8f00551/40035_2024_448_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/bfc78a0e50f3/40035_2024_448_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/3c7b29334689/40035_2024_448_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/8a348d584021/40035_2024_448_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/99553fa13fb4/40035_2024_448_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/c8ee1136b536/40035_2024_448_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/42e5675422d4/40035_2024_448_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/6b03b6499dba/40035_2024_448_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/90dcdde67bbd/40035_2024_448_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/387ff8f00551/40035_2024_448_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/bfc78a0e50f3/40035_2024_448_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/3c7b29334689/40035_2024_448_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/8a348d584021/40035_2024_448_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/99553fa13fb4/40035_2024_448_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/c8ee1136b536/40035_2024_448_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e290/11648304/42e5675422d4/40035_2024_448_Fig9_HTML.jpg

相似文献

1
Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson's model.在人脑中脑帕金森病模型中,星形胶质细胞促成Toll样受体2介导的神经退行性变和α-突触核蛋白病理改变。
Transl Neurodegener. 2024 Dec 16;13(1):62. doi: 10.1186/s40035-024-00448-3.
2
Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein.α-突触核蛋白原纤维小鼠模型中的神经病理学发生与帕金森病相关的溶酶体 ATP13A2 蛋白无关。
Neurobiol Dis. 2024 Nov;202:106701. doi: 10.1016/j.nbd.2024.106701. Epub 2024 Oct 13.
3
Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.黑质反应性神经胶质细胞的神经炎症基因表达谱提示α-突触核蛋白包涵体存在多维免疫反应。
Neurobiol Dis. 2024 Feb;191:106411. doi: 10.1016/j.nbd.2024.106411. Epub 2024 Jan 14.
4
Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.帕金森病中神经元、星形胶质细胞和少突胶质细胞α-突触核蛋白病理的神经病理学阶段。
Acta Neuropathol Commun. 2025 Feb 11;13(1):25. doi: 10.1186/s40478-025-01944-x.
5
Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.神经元α-突触核蛋白毒性是多系统萎缩中神经退行性变的关键驱动因素。
Brain. 2025 Jul 7;148(7):2306-2319. doi: 10.1093/brain/awaf030.
6
Templating of monomeric alpha-synuclein results in inflammation and SNpc dopamine neuron death in a genetic mouse model of induced synucleinopathy.在诱导性突触核蛋白病的基因小鼠模型中,单体α-突触核蛋白的模板化会导致炎症和黑质致密部多巴胺能神经元死亡。
Sci Rep. 2025 Jul 22;15(1):26537. doi: 10.1038/s41598-025-10705-8.
7
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils.携带LRRK2 G2019S的星形胶质细胞通过miR-22-5p表现出簇集蛋白伴侣水平升高,且摄取α-突触核蛋白原纤维的能力降低。
Acta Neuropathol Commun. 2025 May 12;13(1):98. doi: 10.1186/s40478-025-02015-x.
8
N-terminus α-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson's disease.N端α-突触核蛋白检测揭示了多系统萎缩症和帕金森病中新型且更多样化的聚集体形态。
Transl Neurodegener. 2024 Dec 27;13(1):67. doi: 10.1186/s40035-024-00456-3.
9
Cntnap4 partial deficiency exacerbates α-synuclein pathology through astrocyte-microglia C3-C3aR pathway.Cntnap4 部分缺失通过星形胶质细胞-小胶质细胞 C3-C3aR 途径加剧α-突触核蛋白病理。
Cell Death Dis. 2023 Apr 22;14(4):285. doi: 10.1038/s41419-023-05807-y.
10
GDNF attenuates a-synuclein aggregation-induced damage to VTA-NAc dopaminergic transmission and alleviates depression-like behaviors in mice.胶质细胞源性神经营养因子减轻α-突触核蛋白聚集诱导的对腹侧被盖区-伏隔核多巴胺能传递的损伤,并减轻小鼠的抑郁样行为。
Sci Rep. 2025 Aug 21;15(1):30804. doi: 10.1038/s41598-025-16556-7.

引用本文的文献

1
Beyond Support Cells: Astrocytic Autophagy as a Central Regulator of CNS Homeostasis and Neurodegenerative Diseases.超越支持细胞:星形胶质细胞自噬作为中枢神经系统稳态和神经退行性疾病的核心调节因子
Cells. 2025 Aug 29;14(17):1342. doi: 10.3390/cells14171342.
2
The dual nature of neuroinflammation in networked brain.网络化大脑中神经炎症的双重性质。
Front Immunol. 2025 Aug 20;16:1659947. doi: 10.3389/fimmu.2025.1659947. eCollection 2025.
3
Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review).

本文引用的文献

1
Live cell lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations.在具有LRRK2和GBA1突变的人类分化神经元中,活细胞溶酶体葡糖脑苷脂酶活性与α-突触核蛋白水平相关。
Front Cell Neurosci. 2023 Oct 16;17:1229213. doi: 10.3389/fncel.2023.1229213. eCollection 2023.
2
Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence.α-突触核蛋白:点燃多巴胺能神经元的火花,体外和体内证据。
Int J Mol Sci. 2022 Aug 30;23(17):9864. doi: 10.3390/ijms23179864.
3
Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease.
小胶质细胞中的脂质代谢:神经退行性疾病的新机制与治疗机遇(综述)
Int J Mol Med. 2025 Sep;56(3). doi: 10.3892/ijmm.2025.5580. Epub 2025 Jul 11.
星形胶质细胞在治疗帕金森病 α-突触核蛋白病中的治疗作用。
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2110746119. doi: 10.1073/pnas.2110746119. Epub 2022 Jul 15.
4
A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology.一种小分子 Toll 样受体拮抗剂可挽救α-突触核蛋白纤维病理学。
J Biol Chem. 2022 Aug;298(8):102260. doi: 10.1016/j.jbc.2022.102260. Epub 2022 Jul 13.
5
Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.人类中脑的单细胞测序揭示胶质细胞的激活和帕金森特异性神经元状态。
Brain. 2022 Apr 29;145(3):964-978. doi: 10.1093/brain/awab446.
6
The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease.LRRK2 G2019S 突变通过细胞外囊泡改变星形胶质细胞到神经元的通讯,并在帕金森病的人诱导多能干细胞衍生模型中诱导神经元萎缩。
Elife. 2021 Sep 30;10:e73062. doi: 10.7554/eLife.73062.
7
Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo.选择性靶向 TLR2/MyD88/NF-κB 通路可减少α-突触核蛋白在体外和体内的传播。
Nat Commun. 2021 Sep 10;12(1):5382. doi: 10.1038/s41467-021-25767-1.
8
Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB.纤维状α-突触核蛋白通过 RIP 激酶信号和 NF-κB 诱导神经毒性星形胶质细胞活化。
Cell Death Dis. 2021 Jul 31;12(8):756. doi: 10.1038/s41419-021-04049-0.
9
Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.源自人脑中脑组织类器官的神经干细胞作为治疗帕金森病的稳定来源:中脑组织类器官-神经干细胞(Og-NSC)作为 PD 治疗的稳定来源。
Prog Neurobiol. 2021 Sep;204:102086. doi: 10.1016/j.pneurobio.2021.102086. Epub 2021 May 28.
10
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.先天免疫受体刺激对脑驻留细胞摄取和降解细胞外α-突触核蛋白的影响。
Exp Mol Med. 2021 Feb;53(2):281-290. doi: 10.1038/s12276-021-00562-6. Epub 2021 Feb 16.